A longitudinal seroprevalence study in a large cohort of working adults reveals that neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independent of the severity of symptoms. Preprint

A longitudinal seroprevalence study in a large cohort of working adults reveals that neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independent of the severity of symptoms. Preprint

搜集汇总

背景与挑战

背景概述

该数据集基于一项针对在职成年人的纵向血清阳性率研究，其核心发现是中和性SARS-CoV-2 RBD特异性抗体在感染后可持续存在至少六个月，且该持久性与症状严重程度无关。这是一份预印本研究成果。